Posts by medifocus

The Prolieve® Thermodilatation System

Posted by on Jan 8, 2013 in slider | 0 comments

The Prolieve® Thermodilatation System

The Prolieve System Website The Prolieve system provides a 45-minute in-office treatment that combines our microwave thermotherapy capability with a proprietary balloon compression technology to both heat the prostate and dilate the prostatic urethra. The purpose of the Prolieve system is to provide a relatively painless and effective alternative to drug therapy and certain types of surgical procedures to treat the symptoms of BPH. Click on the button below to see our information on The Prolieve System. Our Prolieve Thermodilatation...

Read More

Raising the standards of care

Posted by on Dec 11, 2012 in slider | 0 comments

Raising the standards of care

With our proprietary focused heat technology platforms, our treatments are minimally invasive, non-toxic. We are leading the way in new developments in cancerous and non-cancerous treatments for breast disease and BPH.

Read More

Improve the Outcome

Posted by on Dec 10, 2012 in slider | 0 comments

Improve the Outcome

Our goal is to improve outcomes and standards of care in cancerous and non-cancerous treatments. Clinical studies have demonstrated that when used in conjunction with chemotherapy for breast cancer, Medifocus’ patented APA system can significantly increase tumor shrinkage by 50 percent. For BPH, the Prolieve system has shown it can significantly decrease the American Urological Association (AUA) symptom scores.

Read More

Medical Professionals

Posted by on Dec 9, 2012 in slider | 0 comments

Medical Professionals

Medifocus develops and commercializes minimally invasive treatment systems used in treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostatic Hyperplasia (“BPH”).  The Company owns two technology platforms with comprehensive US and international patent protection: 1. The “Endo-thermotherapy Platform”, and 2. The “Adaptive Phased Array Microwave Focusing Platform”. The Company has received regulatory approvals to complete the APA 1000’s pivotal Phase-III clinical trials, the final step before marketing approval. The U.S....

Read More

Minimally Invasive

Posted by on Dec 8, 2012 in slider | 0 comments

Minimally Invasive

Our focused heat treatment systems are designed with patients’ needs and comfort in mind. They are minimally invasive, nontoxic, and have little to no side effects.

Read More